Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya

Archives of Virology, Supplement

Volumn 1996, Issue 11, 1996, Pages 101-114

  Johnson, E D ^a   Johnson, B K ^b   Silverstein, D ^c   Tukei, P ^b   Geisbert, T W ^a   Sanchez, A N ^d   Jahrling, P B ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Nairobi Hospital   (Kenya)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; VIRUS PROTEIN;

ADOLESCENT; ADRENAL CORTEX; ANIMAL; ARTICLE; CASE REPORT; CERCOPITHECUS; CLASSIFICATION; COMPARATIVE STUDY; ELECTRON MICROSCOPY; FATALITY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KENYA; MACACA; MALE; MARBURG VIRUS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SERODIAGNOSIS; VERO CELL; VIROLOGY; VIRUS HEMORRHAGIC FEVER;

ADOLESCENT; ADRENAL CORTEX; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; FATAL OUTCOME; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HUMANS; KENYA; MACACA MULATTA; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; VERO CELLS; VIRAL PROTEINS;

EID: 0029688444     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-7482-1_10     Document Type: Article

References (21)

1. Arata AA, Johnson BK (1978) Approaches towards studies of potential reservoirs of viral haemorrhagic fever in Southern Sudan (1977). In: Pattyn SR (ed) Ebola virus hemorrhagic fever. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 191-200
2. Centers for Disease Control and Prevention (1995) Update: outbreak of Ebola viral haemorrhagic fever-Zaire, 1995. MMWR 44: 381-382
3. Centers for Disease Control (1995) Management of patients with suspected viral haemorrhagic fever. MMWR 44: 475-479
4. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
5. Clauss A (1957) Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 17: 237-246
6. Conrad JL, Isaacson M, Smith EB, Wulff H, Grees M, Gildenhags P, Johnson J (1978) Epidemiologic investigation of Marburg virus disease South Africa, 1975. Am J Trop Med Hyg 27: 1210-1215
7. Feldmann H, Klenk HD, Sanchez A (1993) Molecular biology and evolution of filoviruses. In: Kaaden OR, Eichhorn W, Czerny CP (eds) Unconventional agents and unclassified viruses. Recent advances in biology and epidemiology. Springer, Wien New York, pp 81-100 (Arch Virol [Suppl] 7)
8. Geisbert TW, Jahrling PB (1995) Differentiation of filoviruses by electron microscopy. Virus Res 39: 129-150
9. Gear IS, Cassel GA, Geor AJ, Troppler B, Clausen L, Meyers AM, Kew MC, Bothwell TH, Sher R, Miller GB, Schneider J, Koomhof HJ, Compels ED, Isaacson M, Geor JHS (1975) Outbreak of Marburg virus disease in Johannesburg. Br Med J 4: 489-493
10. Hawiger J (1980) Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med 75: 93-108
11. Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, Peters CJ (1996) Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. In: Schwarz TF, Siegl G (eds) Imported virus infections. Springer, Wien New York, pp 115-134 (Arch Virol [Suppl] 11)
12. Jahrling PB (1995) Filoviruses and arena viruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 6th ed. ASM Press, Washington, pp 1068-1081
13. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ (1990) Preliminary report: isolation of Ebola virus from monkeys imported to the USA. Lancet 335: 502-505
14. Johnson KM, Elliott LH, Heymann DL (1981) Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. J Clin Microbiol 14: 527-529
15. Martini GA, Knauff HG, Schmidt HA, Mayer G, Baetzer G (1968) A hitherto unknown infectious disease contracted from monkeys. Marburg virus disease. Ger Med Mon 13: 457-470
16. Le Guenno B, Formentry P, Wyers M, Gounon P, Walker F, Boesch C (1995) Isolation and partial characterization of a new strain of Ebola virus. Lancet 345: 1271-1274
17. Peters CJ, Sanchez A, Feldmann A, Rollin PE, Nichol S, Ksiazek TG (1994) Filoviruses as emerging pathogens. Semin Virol 5: 147-154
18. Siegert R (1970) The Marburg virus (vervet monkey agent). Mod Trends Med Virol 32: 204-240
19. Simpson DIH, Zlotnbik I, Rutter DA (1968) Vervet monkey disease. Experimental infection of guinea pigs and monkeys with the causative agent. Br J Exp Pathol 69: 458-464
20. Smith DH, Johnson BK, Isaacson M, Swanepoel R, Johnson KM, Kiley MP, Bagshawe A, Siangok T, Keruga W (1982) Marburg virus disease in Kenya. Lancet i: 816-820
21. Triplett DA, Smith C (1982) Routine testing in the coagulation laboratory. In: Triplett DA (ed) Laboratory evaluation of coagulation. American Society of Clinical Pathologists Press, Chicago, pp 27-52